Mizuho Maintains Buy on Elevance Health, Raises Price Target to $585
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Ann Hynes maintains a Buy rating on Elevance Health (ELV) and raises the price target from $575 to $585.

April 24, 2024 | 11:01 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Mizuho analyst Ann Hynes maintains a Buy rating on Elevance Health and raises the price target from $575 to $585.
The increase in price target by Mizuho reflects a positive outlook on Elevance Health's stock, suggesting potential upside. This analyst endorsement could lead to increased investor confidence and a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100